AGA Community: Talking GERD

Chat with colleagues about the latest advances and challenging cases.

Preparing for the GI Boards: What You Need to Know

Share Your Thoughts on Quality Measures That Will Work for You

Final Weeks Approaching to Nominate Outstanding AGA Members

AGA Community: Talking GERD

Preparing for the GI Boards: What You Need to Know

Share Your Thoughts on Quality Measures That Will Work for You

Final Weeks Approaching to Nominate Outstanding AGA Members

News

Filter
  • All
  • Celiac Disease
  • Colorectal Cancer
  • Endoscopy
  • GERD
  • Hepatitis C
  • IBD
  • Advocacy
  • Cancer prevention and treatment
  • GI practice & quality
  • Gut Microbiome & FMT
  • Hepatology
  • Lower GI disorders & procedures
  • Obesity & nutrition
  • Pancreaticobiliary disorders & procedures
  • Pediatric Gastroenterology
  • Procedures
  • Regulatory Peptides, Cell Signaling & Molecular Biology
  • Upper GI disorders & procedures

Gastroenterology

Opportunities and Challenges for Pancreatic Circulating Tumor Cells

Aug. 25, 2016

Standardization of methodologies and prospective studies are needed for this emerging technology to have a significant effect on clinical care for pancreatic cancer.

Gastroenterology

Commensal-Specific CD4+ Cells From Patients With Crohn’s Disease Have a T-Helper 17 Inflammatory Profile

Aug. 25, 2016

We investigated the antigen-specificity of T cells isolated from patients with CD.

Gastroenterology

Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer

Aug. 25, 2016

We investigated whether immunization of infants against HBV prevents their developing HCC as adults. We also searched for strategies to maximize the cancer-preventive effects.

Gastroenterology

Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia

Aug. 25, 2016

We developed a model to determine whether a MT-sDNA test that detects CRC with higher sensitivity and lower specificity than the (FIT) can be used in screening.

Gastroenterology

Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System

Aug. 25, 2016

We investigated the real-world effectiveness of sofosbuvir, ledipasvir/sofosbuvir, and paritaprevir/ritonavir/ombitasvir and dasabuvir in the treatment of hepatitis C.

News

Upcoming AGA Webinar: Review of Pancreatic Cyst Guidelines

Aug. 25, 2016

Join authors of the guideline and technical review to discuss the evidence behind the guideline.

News

The Correct Answer Is …

Aug. 25, 2016

On Monday, we asked members in AGA Community a question from DDSEP® 8 for board exam practice. Did you get it right?
Advertisement

News

Moving Targets: Latest AGA Practice Management Updates

Aug. 24, 2016

Dr. Sarah Streett introduces a new set of articles to help your practice of GI and patient care.